beluga health semaglutide Medical Weight Loss Houston Semaglutide –

6mGLP-1 was administrated into mice via oral gavage

DREAMS-3 Study Design: Head-to-Head Evaluation of Mazdutide vs Semaglutide Efficacy DREAMS-3 is a multicenter, randomized, open-label Phase III clinical trial and the first study to directly compare a GCG/GLP-1 dual receptor agonist with a traditional GLP-1 single-pathway therapy in patients with type 2 diabetes with obesity

Shrimanker I, Bhattarai S

This infusion helps restore depleted glutamine levels, supports fast recovery, protects muscle mass, and improves gut integrity in serious medical conditions

Studies show these dual actionsreduced hunger and decreased food rewardwork synergistically to lower total daily calorie intake without requiring extreme willpower